Company news

Vectus Biosystems Limited news in 2026

Vectus Biosystems Limited's news releases, calls and decks from 2026, newest first.

View company

FDA Pre-IND Meeting Request Granted for VB0004

September 29, 2026

Placement of Shares

May 22, 2026

Appointment of Dr Tara Speranza as CEO & CTO

May 7, 2026

VB4-P5 Renal Compound Transaction Settled

April 13, 2026

Half Year Report & Appendix 4D

February 26, 2026

Quarterly Activities & Appendix 4C Cash Flow Reports

January 30, 2026

Decks in 2026